These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4626940)

  • 21. [Our previous experiences with thio-TEPA in therapy and prevention of bladder papilloma].
    Zingg E; Rutishauser G
    Helv Chir Acta; 1967 Aug; 34(4):353-8. PubMed ID: 4969477
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council Working Party on Urological Cancer, Subgroup on Superficial Bladder Cancer.
    Br J Urol; 1994 Jun; 73(6):632-8. PubMed ID: 8032829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis].
    Lunglmayr G
    Wien Klin Wochenschr; 1971 Jul; 83(27):526-8. PubMed ID: 5001284
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intravascular thio-tepa in the treatment of papillary neoplasms of the bladder].
    Furnari S; Lattuca C; Pavone-Macaluso M; Leone G
    Arch Ital Urol Nefrol; 1968; 41(3):187-98. PubMed ID: 4982415
    [No Abstract]   [Full Text] [Related]  

  • 25. Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.
    Lunglmayr G; Czech K
    J Urol; 1971 Jul; 106(1):72-4. PubMed ID: 4998357
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adjuvant thio-tepa in the treatment of bladder papilloma. A prospective randomized study].
    Malling N; Sørensen SS
    Ugeskr Laeger; 1980 Jun; 142(26):1678-9. PubMed ID: 6773198
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

  • 29. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of local chemotherapy and immunotherapy on the recurrence and progression of superficial bladder cancer.
    Novak R; Kern J; Fister H; Trnski D; Dimanovski J; Kraus O
    Eur Urol; 1988; 14(5):367-70. PubMed ID: 3139417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usual harmlessness of endovesical instillations of thio-tepa].
    des Roseaux M; Vacant J; Beurton D; Cukier J
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):485-7. PubMed ID: 4216647
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
    Kierfeld G; Mellin P
    Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
    [No Abstract]   [Full Text] [Related]  

  • 34. Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors.
    Llopis B; Gallego J; Mompó JA; Boronat F; Jiménez JF
    Eur Urol; 1985; 11(2):73-8. PubMed ID: 3924624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The recurrence after conservative therapy of bladder cancer. II: The intravesical instillation of anti-cancer drug for preventing recurrence (author's transl)].
    Saito K; Fukushima S; Takahashi Y; Takai S
    Nihon Hinyokika Gakkai Zasshi; 1980 May; 71(5):449-57. PubMed ID: 6774151
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
    Dobrzecki W; Kaczmarek A
    Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
    Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
    Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
    Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.